FI962022L - 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina - Google Patents
5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina Download PDFInfo
- Publication number
- FI962022L FI962022L FI962022A FI962022A FI962022L FI 962022 L FI962022 L FI 962022L FI 962022 A FI962022 A FI 962022A FI 962022 A FI962022 A FI 962022A FI 962022 L FI962022 L FI 962022L
- Authority
- FI
- Finland
- Prior art keywords
- protease inhibitors
- antiviral agents
- dihydropyrone derivatives
- dihydropyrone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15544393A | 1993-11-19 | 1993-11-19 | |
| US08/319,820 US5840751A (en) | 1993-11-19 | 1994-10-12 | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| PCT/US1994/012269 WO1995014012A1 (en) | 1993-11-19 | 1994-10-26 | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI962022A0 FI962022A0 (fi) | 1996-05-13 |
| FI962022L true FI962022L (fi) | 1996-07-12 |
| FI962022A7 FI962022A7 (fi) | 1996-07-12 |
Family
ID=26852338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI962022A FI962022A7 (fi) | 1993-11-19 | 1994-10-26 | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraali sina aineina |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0729464A1 (fi) |
| JP (1) | JP3684426B2 (fi) |
| AT (1) | ATE263761T1 (fi) |
| AU (1) | AU689158B2 (fi) |
| CA (1) | CA2176043A1 (fi) |
| DE (1) | DE69433705T2 (fi) |
| DK (1) | DK1142887T3 (fi) |
| ES (1) | ES2219457T3 (fi) |
| FI (1) | FI962022A7 (fi) |
| HR (1) | HRP940935B1 (fi) |
| HU (1) | HUT77668A (fi) |
| IL (1) | IL111674A0 (fi) |
| NO (1) | NO316172B1 (fi) |
| NZ (1) | NZ275961A (fi) |
| PT (1) | PT1142887E (fi) |
| RU (1) | RU2140917C1 (fi) |
| SI (1) | SI1142887T1 (fi) |
| WO (1) | WO1995014012A1 (fi) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69624492T2 (de) * | 1995-08-11 | 2003-06-26 | Zenon Environmental Inc., Oakville | Vertikaler strang von hohlfasermembranen und verfahren zur aufrechterhaltung sauberer faseroberflächen |
| US5834506A (en) * | 1996-11-01 | 1998-11-10 | Warner-Lambert Company | Dihydropyrones with improved antiviral activity |
| SK284974B6 (sk) * | 1997-09-11 | 2006-03-02 | Pharmacia & Upjohn Company | Medziprodukty na výrobu a spôsob výroby proteázového inhibítora |
| CA2339275A1 (en) * | 1998-09-11 | 2000-03-23 | Warner-Lambert Company | 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors |
| US6288235B1 (en) | 1999-04-14 | 2001-09-11 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries |
| DE10030094A1 (de) * | 2000-06-19 | 2001-12-20 | Bayer Ag | Phenylsubstituierte 5,6-Dihydro-pyron-Derivate |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| DE10108471C1 (de) | 2001-02-22 | 2002-11-21 | Boehringer Ingelheim Pharma | Kontinuierliches Verfahren zur Herstellung von 5,6-Dihydro-4-hydroxy-2-pyronen |
| US6500963B2 (en) | 2001-02-22 | 2002-12-31 | Boehringer Ingelheim Pharma Kg | Process for preparing optically active dihydropyrones |
| US7141681B2 (en) | 2001-02-22 | 2006-11-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Continuous process for preparing dihydropyrones |
| DE10108470A1 (de) * | 2001-02-22 | 2002-09-05 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung optisch aktiver Dihydropyrone |
| TW200307667A (en) | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| DOP2003000641A (es) | 2002-05-10 | 2003-11-15 | Pfizer | Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan |
| TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
| US7148226B2 (en) | 2003-02-21 | 2006-12-12 | Agouron Pharmaceuticals, Inc. | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| SE0302487D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| UA88909C2 (ru) | 2004-08-18 | 2009-12-10 | Пфайзер Инк. | Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с, фармацевтическая композиция на их основе и их применение |
| DE102005059469A1 (de) | 2005-12-13 | 2007-06-14 | Bayer Cropscience Ag | Insektizide Zusammensetzungen mit verbesserter Wirkung |
| DE102006007882A1 (de) | 2006-02-21 | 2007-08-30 | Bayer Cropscience Ag | Cycloalkyl-phenylsubstituierte cyclische Ketoenole |
| EP2404912A3 (en) * | 2006-06-16 | 2012-07-25 | Pharma Mar S.A. | Process and intermediates for the preparation of antitumoral dihydropyran-2-one compounds |
| AU2010223535B2 (en) | 2009-03-11 | 2015-09-10 | Bayer Intellectual Property Gmbh | Halogenalkylmethylenoxy-phenyl-substituted ketoenols |
| DE102010008644A1 (de) | 2010-02-15 | 2011-08-18 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Zyklische Ketoenole zur Therapie |
| RU2461555C1 (ru) * | 2011-07-07 | 2012-09-20 | Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" | Способ получения 5-арил-3-фенил-2-оксаспиро[5,6]додец-3-ен-1-онов, проявляющих анальгетическую активность |
| UA113753C2 (xx) | 2012-01-26 | 2017-03-10 | Фенілзаміщені кетоеноли для боротьби з паразитами риб | |
| KR20150090912A (ko) | 2012-11-28 | 2015-08-06 | 스미또모 가가꾸 가부시끼가이샤 | 디히드로피론 화합물 및 상기를 포함하는 제초제 |
| SE539512C2 (sv) | 2015-12-02 | 2017-10-03 | Ultupharma Ab | Compounds and methods of treating bacterial infections |
| CN115916752B (zh) * | 2020-06-26 | 2025-05-06 | 日本农药株式会社 | 芳基四氢吡啶衍生物或其盐类、和含有该化合物的杀虫剂及其使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3818046A (en) * | 1972-12-18 | 1974-06-18 | Dow Chemical Co | Sulfur-containing hydroxy pyrones and alkali metal salts thereof |
| CH617569A5 (en) * | 1975-09-29 | 1980-06-13 | Ciba Geigy Ag | Pesticides containing, as active ingredient, a 3-N-phenyl-carbamoyl-4-hydroxy-1,2-(benzo)pyrone derivative. |
| SU950728A1 (ru) * | 1981-01-23 | 1982-08-15 | Пермский государственный фармацевтический институт | Способ получени 6-арил-3-ароил-4-окси-5-бромпиран-2-онов |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
-
1994
- 1994-10-26 EP EP95900429A patent/EP0729464A1/en not_active Withdrawn
- 1994-10-26 ES ES01114943T patent/ES2219457T3/es not_active Expired - Lifetime
- 1994-10-26 DE DE69433705T patent/DE69433705T2/de not_active Expired - Fee Related
- 1994-10-26 FI FI962022A patent/FI962022A7/fi unknown
- 1994-10-26 AU AU81256/94A patent/AU689158B2/en not_active Ceased
- 1994-10-26 RU RU96113098/04A patent/RU2140917C1/ru not_active IP Right Cessation
- 1994-10-26 WO PCT/US1994/012269 patent/WO1995014012A1/en not_active Ceased
- 1994-10-26 SI SI9430463T patent/SI1142887T1/xx unknown
- 1994-10-26 DK DK01114943T patent/DK1142887T3/da active
- 1994-10-26 AT AT01114943T patent/ATE263761T1/de not_active IP Right Cessation
- 1994-10-26 HU HU9601348A patent/HUT77668A/hu not_active Application Discontinuation
- 1994-10-26 NZ NZ275961A patent/NZ275961A/en unknown
- 1994-10-26 JP JP51445895A patent/JP3684426B2/ja not_active Expired - Fee Related
- 1994-10-26 PT PT01114943T patent/PT1142887E/pt unknown
- 1994-10-26 CA CA002176043A patent/CA2176043A1/en not_active Abandoned
- 1994-11-17 IL IL11167494A patent/IL111674A0/xx unknown
- 1994-11-17 HR HR940935A patent/HRP940935B1/xx not_active IP Right Cessation
-
1996
- 1996-05-15 NO NO19962017A patent/NO316172B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL111674A0 (en) | 1995-01-24 |
| HRP940935A2 (en) | 1997-04-30 |
| DK1142887T3 (da) | 2004-06-21 |
| DE69433705D1 (de) | 2004-05-13 |
| HUT77668A (hu) | 1998-07-28 |
| CA2176043A1 (en) | 1995-05-26 |
| JPH09505294A (ja) | 1997-05-27 |
| NO962017L (no) | 1996-07-08 |
| HU9601348D0 (en) | 1996-07-29 |
| PT1142887E (pt) | 2004-08-31 |
| AU689158B2 (en) | 1998-03-26 |
| RU2140917C1 (ru) | 1999-11-10 |
| DE69433705T2 (de) | 2005-03-10 |
| ES2219457T3 (es) | 2004-12-01 |
| ATE263761T1 (de) | 2004-04-15 |
| NO316172B1 (no) | 2003-12-22 |
| AU8125694A (en) | 1995-06-06 |
| SI1142887T1 (en) | 2004-08-31 |
| NZ275961A (en) | 2001-11-30 |
| NO962017D0 (no) | 1996-05-15 |
| WO1995014012A1 (en) | 1995-05-26 |
| FI962022A0 (fi) | 1996-05-13 |
| JP3684426B2 (ja) | 2005-08-17 |
| HRP940935B1 (en) | 2004-08-31 |
| EP0729464A1 (en) | 1996-09-04 |
| FI962022A7 (fi) | 1996-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962022L (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| DE69434214D1 (de) | HIV protease inhibitoren | |
| NO942064D0 (no) | yminhibitorer | |
| FI943976A7 (fi) | 5-aryyli-indolijohdannaiset | |
| FI955316A7 (fi) | Vitamiini D:n amidijohdannaisia | |
| FI962021L (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| FI962488A7 (fi) | HIV:n proteaasin inhibiittoreita | |
| FI945674A7 (fi) | Substituoidut 2beta-morfoliini-androstaanijohdannaiset | |
| ZA949148B (en) | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents | |
| FI942444A7 (fi) | Terahydropyraanijohdannaisia | |
| ZA949150B (en) | Pyrone derivatives as protease inhibitors and antiviral agents. | |
| FI943885L (fi) | Penaami-johdannaiset | |
| FI950586A0 (fi) | Aminohappojohdos | |
| FI944044L (fi) | Fenyylialkanoliamiinijohdannaiset | |
| FI941149A7 (fi) | 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia | |
| FI962019L (fi) | Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| FI962020L (fi) | Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| DE59407726D1 (de) | 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate | |
| FI956045L (fi) | Antiparasiittisina aineina käyttökelpoiset 14-substituoidut markfortiinit ja johdannaiset | |
| NO950327D0 (no) | Pyridoindolobenzodiazepiner og derivater som antipsykotiske midler | |
| DE69400388D1 (de) | Cyclohexendiolderivate | |
| KR930021222U (ko) | 스패너 | |
| SI0729465T1 (en) | Pyrone derivatives as protease inhibitors and antiviral agents | |
| NO934473D0 (no) | N-substituerte azabicykloheptanderivater | |
| FI933459A0 (fi) | Vaermevaexlare i kombination med varmvatten- och aongberedarpanna |